LivaNova prepares to go live; Corvia raises $17M for heart failure device;

@FierceMedDev: ICYMI: LabCorp, China's Fosun Pharma, lead Asia-heavy $15B investment in Ativa Medical. FierceDiagnostics Item | Follow @FierceMedDev

@VarunSaxena2: Four key medical device recalls of 2015. Feature | Follow @VarunSaxena2

@EmilyWFierce: Human Longevity joins with South African insurer for $250 exome sequencing service. FierceDiagnostics story | Follow @EmilyWFierce

> The Brits have signed off on the merger of Sorin and Cyberonics ($CYBX). It's all slated for the newly resulting LivaNova to be a done deal on Oct. 19. More

> Corvia Medical has gotten a second $17 million tranche to reach $34 million to back first transcatheter device designed to treat diastolic heart failure. SEC filing

> Xenios has raised an undisclosed, 8-figure sum in a financing led by ZFHN for its next-gen lung and heart support devices. More

Biotech News

@FierceBiotech: GlaxoSmithKline's asthma injection heads for EU approval. Story | Follow @FierceBiotech

@JohnCFierce: ICYMI: BIO boots Martin Shkreli's Turing out after pricing controversy erupts. Article | Follow @JohnCFierce

@DamianFierce: Hard to believe but the pope just described biotech valuations as "stretched." | Follow @DamianFierce

> Next-gen oncolytics upstart Replimune grabs a $30M transatlantic venture round. Report

> Concert Pharma's CF drug tops Vertex's top-seller in early study. Story

> GlaxoSmithKline's asthma injection heads for EU approval. Article

Pharma News

@FiercePharma: Mylan leverages marketing savvy, price hikes to make EpiPen a go-to med. More | Follow @FiercePharma

@EricPFierce: We all know about drug recalls but who tops the list for device recalls? FierceMedicalDevices feature | Follow @EricPFierce

> Novartis brings heart, cancer meds to low-income countries for $1 per month. More

> U.S. cancer drug prices up to 3X higher than in Europe: Study. Article

Vaccines News

> IDRI, Wellcome Trust to take tuberculosis jab to PhIIa in South Africa. Story

> Inovio-led team picks up $24M from DARPA to develop Ebola vaccine, treatments. Report

> Serum Institute sets out for dengue fast track. Article

> Scripps Florida nets 4-year, $6M grant from Gates Foundation for HIV vaccine. Story

> Advaxis reports 'encouraging' PhII cervical cancer vaccine data. More

CRO News

> U.K. CRO Venn buys up another contractor. Item

> ShangPharma plots a $60M splash for biologics R&D in China. Story

> German CRO cozies up to Bayer at its Berlin R&D hub. More

> Covance plots a deeper dive into manufacturing. Story

> BioClinica reaches into regulatory affairs with its latest buy. Article

Pharma Manufacturing News

> World's largest reinsurer ready to insure against FDA actions. Report

> Sun Pharma recalls more than 216,000 bottles after label leaches chemical. News

> Aesica plant to get power from biomass plant. More

> Mayne kicks off work on new $65M North Carolina plant. Story

> Pfizer finds buyer for Indian plant set to close this month. Article

Pharma Asia News

> Serum Institute of India throttles back on equity sale. Item

> China-focused RuiYi starts PhI in China on autoimmune candidate RYI-008. News

> HK-listed Lee's Pharmaceutical branches out further with Armetheon deal. More

> Japan's MHLW lines up about 50 candidates for fast-track 'sakigake' process. Story

> Australian subsidies for newer drugs go begging as companies avoid paper chase. Article